Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

Robotic surgery does not improve outcomes in total hip or knee replacement when compared with conventional surgery.

GLP-1 RAs outperformed mineralocorticoid receptor antagonists (MRAs) in cardiovascular protection in resistant hypertension and obesity.

Despite higher costs, Medicare Advantage does not improve glycemic control or health-related social needs in patients with type 2 diabetes.

A higher total fat area at the lumbar 1 vertebral level, not higher BMI, is associated with higher non-small cell lung cancer risk.

Low-dose radiotherapy (LDRT) offers multiple benefits in early knee osteoarthritis (OA), according to a study.

Mitochondrial diabetes mellitus prevalence is high among patients with mitochondrial diseases and is strongly associated with specific genotypes.

Researchers evaluated the incidence and risk factors for ketoacidosis among adults with type 2 diabetes receiving treatment with SGLT2 inhibitors.

While lower-frequency IET may be sufficient to maintain BP reductions over the short term, higher frequencies are required to preserve the full CV benefits.

Therapy with GLP-1 RAs reduces the frequency of apnea and hypopnea events in obesity, serving as an effective adjunct to ...

The prevalence of neurodiversity is increased among individuals diagnosed with type 2 diabetes (T2D) early in life.

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.